Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy

Figures & data

Table 1 The initial characteristics of the patients before subthreshold micropulse yellow laser treatment

Initial characteristics
Mean age	36.4 years
Sex	Eleven patients were males, four were females
Mean duration of symptoms	4.6 months
Source of leakage	Ten eyes had unifocal leakage and five eyes had multifocal leakage
	Nine eyes had leakage inside the FAZ and six eyes had leakage outside the FAZ
Pre-laser BCVA	0.67±0.097

Abbreviations: BCVA, best-corrected visual acuity; CSC, central serous chorioretinopathy; FAZ, foveal avascular zone.

Figure 1 Best-corrected visual acuity (BCVA) before and 6 months after micropulse laser treatment.

Figure 2 CMT measured before and 6 months after laser treatment for all patients.

Abbreviations: CMT, central macular thickness; OCT, optical coherence tomography.

Figure 3 A patient with central serous chorioretinopathy of the right eye.

Notes: (A) OCT image showing neurosensory macular detachment (a) with the corresponding CMT of 452 µm (b). (B) Corresponding smoke stack pattern of leakage on fundus fluorescein angiography. (C) OCT image 6 months after micropulse laser therapy with complete resolution of the fluid (a) and CMT of 222 µm (b).
Abbreviations: CMT, central macular thickness; OCT, optical coherence tomography; N, nasal; T, temporal.

Figure 4 A patient with central serous chorioretinopathy of the left eye.

Notes: (A) colored image showing left CSC and (B) the corresponding OCT image, with (C) CMT of 434 µm. (D) OCT image after resolution of the fluid 6 months following subthreshold micropulse laser treatment, with (E) CMT 219 µm.
Abbreviations: CMT, central macular thickness; OCT, optical coherence tomography; N, nasal; T, temporal.